2023 EGFR Resisters/LUNGevity Award Program for EGFR-Positive Lung Cancer
| קרן | LUNGevity |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 27/02/2023 |
| פקולטה | Life Sciences, Medicine |
| תיאור | The goal of the program is to fund research project(s) that will have a direct impact on the outcomes of patients with advanced EGFR-positive lung cancer. However, innovative proposals that address other unmet needs in the EGFR-positive lung cancer space are also invited for submission. International applicants are required to have a US-based partner.
Funding: $200,000 total
Duration: 2 years
Research Authority due date: 20.2.23
LOI (required) due date: 27.2.23
Full proposal due date: 8.5.23
|
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 25/01/2023 |
